SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Ride the Tiger with CD

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ralfph8/12/2022 11:04:47 AM
  Read Replies (1) of 301835
 
MDNA once again from the "go figure" dept comes this bit of news

Medicenna Therapeutics Corp. has closed its previously announced marketed underwritten public offering of units of the company in Canada and in the United States at a price to the public of $1.50 (U.S.) per unit for aggregate gross proceeds to the company of approximately $20-million (U.S.), before deducting underwriting commissions and offering expenses, and excluding any proceeds the company may receive from the exercise of the underlying warrants. Pursuant to the Offering, the Company issued a total of 13,333,334 Units.


The stock is trading at $1.30 Canadian - the raise was done at $1.91 Canadian. Got to wonder why the 60 cent discount. So is the stock a good deal and going to run or is there bad news in the pipe? At this stage what is happening makes little sense.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext